# Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia

> **NCT07473843** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Arrowhead Pharmaceuticals** · enrollment: 12 (estimated)

## Conditions studied

- Homozygous Familial Hypercholesterolemia

## Interventions

- **DRUG:** Zodasiran

## Key facts

- **NCT ID:** NCT07473843
- **Lead sponsor:** Arrowhead Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-07
- **Final completion:** 2029-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473843, "Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07473843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*